2nd NKI-Weizmann Conference

Q: day 2: Tuesday May 9th

08:30 Coffee/tea/program pickup 09:00 Start SESSION 3 09:00-09:30 Igor Ulitsky , Weizmann Institute of Science A GBA pseudogene is essential for survival of senescent cells 09:30-10:00 Daniel Peeper , Netherlands Cancer Institute Function-based genomics to combat immunotherapy resistance 10:00-10:30 Yossi Yarden , Weizmann Institute of Science Mechanisms underlying secondary mutagenesis and resistance of lung cancer to EGFR kinase inhibitors BREAK 11:00-11:30 Jos Jonkers , Netherlands Cancer Institute Modeling breast cancer in mice and rats 11:30-12:00 Ziv Shulman , Weizmann Institute of Science Memories of antibody-mediated immune responses in ovarian cancer patients 12:00-12:30 Reuven Agami , Netherlands Cancer Institute Amino acid shortages in cancer 12:30-13:30 Lunch SESSION 4 13:30-14:00 Benjamin Rowland , Netherlands Cancer Institute Cohesin and chromatin structure 14:00-14:30 Itay Tirosh, Weizmann Institute of Science Pan-cancer analysis of intra-tumor heterogeneity 14:30-15:00 Bas van Steensel , Netherlands Cancer Institute Tools to probe genome regulation 15:00-15:30 Ido Amit , Weizmann Institute of Science The power of ONE: Immunology in the age of spatial and single cell genomics

Exploring uncharted territories in cancer research

Monday 08 May 2023

9am - 6pm

Piet Borst Auditorium

Conference

The second Netherlands Cancer Institute (NKI) - Weizmann Institute of Science (WIS) conference is a sequel to the first successful episode, which was held in Israel in 2016. This conference brings together top scientists from each institute, who will present their latest discoveries. The theme for this year is "Exploring uncharted territories in cancer research". Exciting developments in fundamental, translational and clinical cancer research will be covered. During the conference, there will be sufficient time for discussions and to set up collaborations.

The conference is sponsored by the Friends of the Weizmann Institute, WIS, NKI and Oncode Institute.

(click on the image to enlarge)

The second Netherlands Cancer Institute (NKI) - Weizmann Institute of Science (WIS) conference will be held at the Netherlands Cancer Institute in Amsterdam.

Location
Piet Borst Auditorium
The Netherlands Cancer Institute
Plesmanlaan 121
1066 CX Amsterdam

Organizing Committee

Yardena Samuels, Weizmann Institute of Science
Moshe Oren, Weizmann Institute of Science
Daniel Peeper, The Netherlands Cancer Institute
Reuven Agami, The Netherlands Cancer Institute

Conference catering
During the conference, complimentary coffee and tea will be provided to all attendees. A complimentary lunch box will be available if registered and indicated on the registration form.

For questions, please contact Lisa Dicke at l.dicke@nki.nl or Anne Nieuwenburg at a.nieuwenburg@nki.nl.

Registration & lunch

Attendance is free of charge but registration is mandatory as available seats are limited. Registration will give you access to a complimentary lunch box.

_{UPDATE: Registration is closed. It's still possible to visit the lectures, however without registration the lunch box won't be available.}

Register here

Program

day 1: Monday May 8th

08:30 Coffee/tea/program pickup

09:00 Welcome

SESSION 1

09:05-09:35 Liran Shlush, Weizmann Institute of Science
The aging of the blood system and leukemia evolution

09:35-10:05 Ton Schumacher, Netherlands Cancer Institute
Immune recognition of cancer

10:05-10:35 Efrat Shema, Weizmann Institute of Science
Decoding the epigenome for cancer research and diagnostics

BREAK

11:00-11:30 Jacco van Rheenen, Netherlands Cancer Institute
Intravital microscopy reveals the plastic nature of cancer growth and metastasis

11:30-12:00 Ayelet Erez, Weizmann Institute of Science
Dissecting the host-tumor metabolic crosstalks to improve cancer therapy

12:00-12:30 Fred van Leeuwen, Netherlands Cancer Institute
Deconstructing chromatin by DNA barcoding

12:30-13:00 Yonina Eldar, Weizmann Institute of Science
Model based deep learning for medical diagnosis

13:00-14:00 Lunch

SESSION 2

14:00-14:30 Thijn Brummelkamp, Netherlands Cancer Institute
Deciphering cellular phenotypes using haploid genetics

14:30-15:00 Ruth Scherz-Shouval, Weizmann Institute of Science
From gatekeepers to providers- cancer associated fibroblasts in the tumor microenvironment

15:00-15:30 Karin de Visser, Netherlands Cancer Institute
Elucidating how the genetic makeup of breast cancer shapes the immune landscape

15:30-16:00 Yardena Samuels, Weizmann Institute of Science
Revisiting the neoantigen approach for cancer immunotherapy

BREAK

16:30-17:00 Tineke Lenstra, Netherlands Cancer Institute
Single molecule transcriptomics

17:00-17:30 Yifat Merbl, Weizmann Institute of Science
Proteasome profiling: from global views of degradation to novel mechanisms of anti-tumor immunity

17:30-18:00 Titia Sixma, Netherlands Cancer Institute
DUB gymnastics: allosteric regulation of deubiquitinating enzymes

day 2: Tuesday May 9th

08:30 Coffee/tea/program pickup

09:00 Start

SESSION 3

09:00-09:30 Igor Ulitsky, Weizmann Institute of Science
A GBA pseudogene is essential for survival of senescent cells

09:30-10:00 Daniel Peeper, Netherlands Cancer Institute
Function-based genomics to combat immunotherapy resistance

10:00-10:30 Yossi Yarden, Weizmann Institute of Science
Mechanisms underlying secondary mutagenesis and resistance of lung cancer to EGFR kinase inhibitors

BREAK

11:00-11:30 Jos Jonkers, Netherlands Cancer Institute
Modeling breast cancer in mice and rats

11:30-12:00 Ziv Shulman, Weizmann Institute of Science
Memories of antibody-mediated immune responses in ovarian cancer patients

12:00-12:30 Reuven Agami, Netherlands Cancer Institute
Amino acid shortages in cancer

12:30-13:30 Lunch

SESSION 4

13:30-14:00 Benjamin Rowland, Netherlands Cancer Institute
Cohesin and chromatin structure

14:00-14:30 Itay Tirosh, Weizmann Institute of Science
Pan-cancer analysis of intra-tumor heterogeneity

14:30-15:00 Bas van Steensel, Netherlands Cancer Institute
Tools to probe genome regulation

15:00-15:30 Ido Amit, Weizmann Institute of Science
The power of ONE: Immunology in the age of spatial and single cell genomics

day 3: Wednesday May 10th

08:30 Coffee/tea

09:00 Start

SESSION 5

09:00-09:30 Emile Voest, Netherlands Cancer Institute
Challenges and opportunities in implementing genomics-guided medicine

09:30-10:00 Valery Krizhanovsky, Weizmann Institute of Science
Molecular mechanisms of senescence on the crossroads of aging and cancer

10:00-10:30 Lodewyk Wessels, Netherlands Cancer Institute
Detecting and exploiting interaction in cancer

BREAK

11:00-11:30 Leila Akkari, Netherlands Cancer Institute
Harnessing the potential of myeloid cells in brain and liver cancer treatment: a matter of genetics, time and combination.

11:30-12:00 Wilbert Zwart, Netherlands Cancer Institute
Plasticity in Androgen Receptor genomics: probing the epigenome that drives prostate cancer development, progression and metastasis

12:00-12:30 Rony Dahan, Weizmann Institute of Science
Optimizing the IgG scaffold of immune checkpoint antibodies

12:30-13:00 Marleen Kok, Netherlands Cancer Institute
Improving immunotherapy for breast cancer patients: bringing preclinical concepts to the clinic

13:00-14:00 Lunch

14:00-14:30 Rene Bernards, Netherlands Cancer Institute
Activation of oncogenic signaling as a cancer treatment strategy

14:30-15:00 Moshe Oren, Weizmann Institute of Science
Modulation of adipocytes by p53 status in breast cancer

15:00-15:30 René Medema, Netherlands Cancer Institute
Optimizing the response to radiotherapy

15:30 Closing remarks

16:00 Departure

2nd NKI-Weizmann Conference

Exploring uncharted territories in cancer research

Registration & lunch

UPDATE: Registration is closed. It's still possible to visit the lectures, however without registration the lunch box won't be available.

Program

This site uses cookies

_{UPDATE: Registration is closed. It's still possible to visit the lectures, however without registration the lunch box won't be available.}